These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 31746422)

  • 1. LncRNA SPRY4‑IT1 promotes progression of osteosarcoma by regulating ZEB1 and ZEB2 expression through sponging of miR‑101 activity.
    Yao H; Hou G; Wang QY; Xu WB; Zhao HQ; Xu YC
    Int J Oncol; 2020 Jan; 56(1):85-100. PubMed ID: 31746422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The microRNA‑708‑5p/ZEB1/EMT axis mediates the metastatic potential of osteosarcoma.
    Feng T; Zhu Z; Jin Y; Wang H; Mao X; Liu D; Li Y; Lu L; Zuo G
    Oncol Rep; 2020 Feb; 43(2):491-502. PubMed ID: 31894343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role and clinical significance of long noncoding RNA zinc finger E-box-binding homeobox two antisense RNA 1 in promoting osteosarcoma cancer cell proliferation, inhibiting apoptosis and increasing migration by regulating miR-145.
    Zhou Y; Feng D; Gu X; Gao A; Liu Y
    Anticancer Drugs; 2021 Feb; 32(2):168-177. PubMed ID: 32826416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. lncRNA nuclear-enriched abundant transcript 1 promotes cell proliferation and invasion by targeting miR-186-5p/HIF-1α in osteosarcoma.
    Tan H; Zhao L
    J Cell Biochem; 2019 Apr; 120(4):6502-6514. PubMed ID: 30485482
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA XIST promotes the epithelial to mesenchymal transition of retinoblastoma via sponging miR-101.
    Cheng Y; Chang Q; Zheng B; Xu J; Li H; Wang R
    Eur J Pharmacol; 2019 Jan; 843():210-216. PubMed ID: 30472203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA XIST promotes osteosarcoma progression by targeting YAP via miR-195-5p.
    Yang C; Wu K; Wang S; Wei G
    J Cell Biochem; 2018 Jul; 119(7):5646-5656. PubMed ID: 29384226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
    Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
    Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of long non-coding RNA NNT-AS1 promotes osteosarcoma progression by inhibiting the tumor suppressive miR-320a.
    Li C; Zhang S; Qiu T; Wang Y; Ricketts DM; Qi C
    Cancer Biol Ther; 2019; 20(4):413-422. PubMed ID: 30489194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-126 Inhibits Proliferation, Migration, Invasion, and EMT in Osteosarcoma by Targeting ZEB1.
    Jiang R; Zhang C; Liu G; Gu R; Wu H
    J Cell Biochem; 2017 Nov; 118(11):3765-3774. PubMed ID: 28379605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 11. Knockdown of lncRNA MEG3 inhibits viability, migration, and invasion and promotes apoptosis by sponging miR-127 in osteosarcoma cell.
    Wang Y; Kong D
    J Cell Biochem; 2018 Jan; 119(1):669-679. PubMed ID: 28636101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The long non-coding RNA-ROR promotes osteosarcoma progression by targeting miR-206.
    Fei D; Sui G; Lu Y; Tan L; Dongxu Z; Zhang K
    J Cell Mol Med; 2019 Mar; 23(3):1865-1872. PubMed ID: 30565392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lncRNA SNHG5-mediated miR-205-5p downregulation contributes to the progression of clear cell renal cell carcinoma by targeting ZEB1.
    Xiang W; Lv L; Zhou G; Wu W; Yuan J; Zhang C; Jiang G
    Cancer Med; 2020 Jun; 9(12):4251-4264. PubMed ID: 32281285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HOTAIR promotes osteosarcoma development by sponging miR-217 and targeting ZEB1.
    Wang B; Qu XL; Liu J; Lu J; Zhou ZY
    J Cell Physiol; 2019 May; 234(5):6173-6181. PubMed ID: 30367466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA GSEC promotes the proliferation, migration and invasion by sponging miR-588/ EIF5A2 axis in osteosarcoma.
    Liu R; Ju C; Zhang F; Tang X; Yan J; Sun J; Lv B; Guo Y; Liang Y; Lv XB; Zhang Z
    Biochem Biophys Res Commun; 2020 Nov; 532(2):300-307. PubMed ID: 32868080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Noncoding RNA CAT104 Promotes Cell Viability, Migration, and Invasion in Gastric Carcinoma Cells Through Activation of MicroRNA-381-Inhibiting Zinc Finger E-box-Binding Homeobox 1 (ZEB1) Expression.
    Yuan G; Quan J; Dong D; Wang Q
    Oncol Res; 2018 Aug; 26(7):1037-1046. PubMed ID: 29295724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA ZEB1-AS1 down-regulation suppresses the proliferation and invasion by inhibiting ZEB1 expression in oesophageal squamous cell carcinoma.
    Zhao Y; Wang N; Zhang X; Liu H; Yang S
    J Cell Mol Med; 2019 Dec; 23(12):8206-8218. PubMed ID: 31638344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR‑498 inhibits the growth and metastasis of liver cancer by targeting ZEB2.
    Zhang X; Xu X; Ge G; Zang X; Shao M; Zou S; Zhang Y; Mao Z; Zhang J; Mao F; Qian H; Xu W
    Oncol Rep; 2019 Mar; 41(3):1638-1648. PubMed ID: 30592286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of long non-coding RNA MALAT1 elevates microRNA-429 to suppress the progression of hypopharyngeal squamous cell carcinoma by reducing ZEB1.
    Liu X; Zhao W; Wang X
    Life Sci; 2020 Dec; 262():118480. PubMed ID: 32980391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA SNHG1 stimulates ovarian cancer progression by modulating expression of miR-454 and ZEB1.
    Wu Y; Zhu B; Yan Y; Bai S; Kang H; Zhang J; Ma W; Gao Y; Hui B; Li R; Zhang X; Ren J
    Mol Oncol; 2021 May; 15(5):1584-1596. PubMed ID: 33641229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.